Home › Employers › STRM.BIO, Inc.
STRM.BIO, Inc.: H-1B salaries and sponsorship
STRM.BIO, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $92,000.
Does STRM.BIO, Inc. sponsor H-1B visas?
STRM.BIO, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 13, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Scientist I, Process Development | 1 | $130,000 |
| Senior Research Associate | 1 | $92,000 |
| Research Associate II | 1 | $90,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $130,000 |
| FY2024 | 2 | $91,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
- Medical Scientists, Except Epidemiologists1
- Molecular and Cellular Biologists1
- Biological Technicians1
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Research Associate II | $90,000–$91,000 Level II | Cambridge, MA | Sep 13, 2024 | Nov 11, 2024 | Certified |
| Senior Research Associate | $92,000–$105,000 Level II | Cambridge, MA | Oct 16, 2023 | Oct 20, 2023 | Certified |
| Scientist I, Process Development | $130,000 Level III | Cambridge, MA | May 16, 2023 | Oct 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).